BridgeMD
New treatment option for Solid Tumors
Official title The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
ClinicalTrials.gov ID: NCT05203172
What this study is testing
What is Binimetinib only treatment?
Binimetinib only treatment is an investigational medicine, being studied as a potential treatment for solid tumors.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this clinical trial (called the FLOTILLA study) is to give continued access to the study medicines, as well as safety follow-up, for participants in prior clinical trials of encorafenib and/or binimetinib. All participants who took part in earlier encorafenib and/or binimetinib studies may participate the FLOTILLA study if they are still benefiting from the use of the study medicines.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Any participant who is receiving study intervention and deriving clinical benefit (as determined by the principal investigator) in an...
- Participants must agree to follow the reproductive criteria as outlined in the applicable Encorafenib/Binimetinib Continuation Sub-Study Protocol.
You likely can't join if
- Any medical reason that, in the opinion of the investigator or sponsor, precludes the participant from inclusion in the study.
The study team makes the final eligibility decision.
Where it's taking place
- Phoenix, Arizona, United States
- Atlanta, Georgia, United States
- Boston, Massachusetts, United States
- Saint Paul, Minnesota, United States
- St Louis, Missouri, United States
- Basking Ridge, New Jersey, United States
- New York, New York, United States
- Durham, North Carolina, United States
- Melbourne, Victoria, Australia
- Natal, Rio Grande do Norte, Brazil
- Ijuí, Rio Grande do Sul, Brazil
- Barretos, São Paulo, Brazil
- São Paulo, São Paulo, Brazil
- Toronto, Ontario, Canada
- Montreal, Quebec, Canada
- Prague, Praha 2, Czechia
- Lille, NORD, France
- Villejuif, Val-de-marne, France
- Tübingen, Baden-Wurttemberg, Germany
- Magdeburg, Saxony-Anhalt, Germany
+ 31 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Phoenix, Arizona, United States; Atlanta, Georgia, United States; Boston, Massachusetts, United States; Saint Paul, Minnesota, United States; St Louis, Missouri, United States; Basking Ridge, New Jersey, United States and 45 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.